Deferoxamine Mesylate: Advanced Strategies for Iron Chela...
2026-01-20
Explore how Deferoxamine mesylate, a leading iron-chelating agent, enables precision modulation of ferroptosis and oxidative stress in advanced disease models. This article delivers novel experimental frameworks and translational insights distinct from conventional reviews.